Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study

Bokyung Kim(Rutgers, The State University of New Jersey), Soo‐Jeong Cho(Seoul National University), Sang Gyun Kim(Seoul National University Hospital), Jin‐Hyung Jung(Samsung (South Korea)), Hyunsoo Chung(Seoul National University), Eunwoo Lee(Seoul National University), Kyungdo Han(Catholic University of Korea), Seungkyung Kang(Seoul National University Hospital)
Journal of Korean Medical Science
January 1, 2023
Cited by 1


Related Papers